Context Capital Management, LLC - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 24 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Context Capital Management, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2021$1,153,000
+0.3%
115,0530.0%0.09%
-23.1%
Q3 2021$1,150,000
-0.5%
115,0530.0%0.12%
+9.3%
Q2 2021$1,156,000
+1.9%
115,0530.0%0.11%
-3.6%
Q1 2021$1,134,000115,0530.11%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2021
NameSharesValueWeighting ↓
Hartree Partners, LP 1,285,000$12,914,250,0003.01%
Wealthspring Capital LLC 277,192$2,786,0000.70%
BASSO CAPITAL MANAGEMENT, L.P. 135,404$1,361,0000.17%
Omni Partners US LLC 364,371$3,662,0000.16%
Sage Mountain Advisors LLC 93,470$939,0000.16%
Castle Creek Arbitrage, LLC 253,446$2,540,0000.14%
Shaolin Capital Management LLC 396,200$3,982,0000.12%
Context Capital Management, LLC 115,053$1,156,0000.11%
PERISCOPE CAPITAL INC. 250,000$2,512,0000.08%
Magnetar Financial LLC 803,400$8,074,0000.08%
View complete list of IBERE PHARMACEUTICALS shareholders